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Diagnostics of Brain Rehabilitation
Nathalie A. Spita, Jillian E. Stafflinger and Andrew K. Ottens
Department of Anatomy & Neurobiology, Virginia Commonwealth University, Richmond, VA 23298

Abstract

Design and Methods

Traumatic brain injury (TBI) is a leading cause of long-term morbidity among the young resulting in significant
societal impacts. Yet advances in TBI therapeutic care have been largely limited by the complexity of the
pathobiology, heterogeneity among patients, and imprecise endpoint assessments with which to evaluate efficacy.
Thus, there remains a significant need for improved diagnostics, particularly for guiding novel therapeutic use and
outcomes. So-called theragnostic assays are of particular interest in the new area of TBI rehabilitation, which ideally
would target a window of heightened brain plasticity during which circuit remodeling would support recapitulation of
lost function. The biochemical processes associated with brain plasticity following TBI produce metabolized
components that are small enough in size to passively diffuse into peripheral fluid and by natural means are
excreted into urine. We employ high performance mass spectrometry to quantify these byproducts, comprising a
“TBI urinary signature” of some 2,500 TBI selective molecules. In this study we hypothesized that the urinary
signature would evolve with the advent of a plasticity window during the course of inpatient rehabilitation. Urine
samples from eight TBI patients were collected at admission and discharge from the VCU Health Science Center
Brain Injury Rehabilitation Unit. Application of non-supervised dimensional reduction analysis demonstrates that the
TBI urinary signature is highly effective at classifying TBI patients from non-traumatized age / sex matched
individuals. Further, our data demonstrate that
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Study Design &Sample Collection
A controlled demographic of young adult Caucasian male subjects was recruited with informed consent and approval by the Virginia
Commonwealth University Institutional Review Board (Richmond, VA). TBI subjects were enrolled upon admission to inpatient
rehabilitation at a mean 22 days post injury (n=8; 26±8 years old; 5 ± 3 Glasgow Coma Scale [GCS] score assessed acutely after injury).
Non-traumatized matched control subjects were then recruited (n=8; 26±8 years old). Criteria excluded subjects with non-cranial bone
fractures, renal dysfunction at time of rehabilitation admission, and a positive history for past brain injury or neurological disease.
Admission to the Brain Injury Rehabilitation Unit was based on standards of care for demonstrating readiness, with required medical
stability and capacity to progress in an acute rehabilitation program. Beginning at the 72 h on unit, three mid-stream urine specimens
were acquired within a 48-h window. Subsequently an additional three mid-stream urine specimens were collected within a 48-h window
approaching discharge of the subject from the Brain Injury Rehabilitation Unit. Urine specimens were placed at 4°C after collection and
centrifuged at 1500xg and 4°C for 15 min. Aliquots were then stored at -80°C.
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Sample Processing
Specimens (six per TBI subject and three per control) were
load-normalized to an osmolarity measure of 130 mOsm/kg
with Nanopure water. Balanced specimens (100 µL) were
filtered with 0.1-µm pore Ultrafree-MC units (Millipore,
Billerica, MA), with the supernatants transferred to vials for
direct injection (8 µL on column) in a group-interspersed
order. Reversed-phase separation was performed with a
nano-Acquity chromatography system, using a Symmetry
C18 trapping column (2 cm x 180 µm i.d.) and an HSS T3
nanoAcquity (15 cm x 75 µm i.d.) capillary column (Waters,
Milford, MA). Components were gradient separated using
0.1% formic acid modified acetonitrile and water. Eluting
analytes were electrosprayed into a Synapt G2 hybrid ion
mobility/mass spectrometer (Waters), operated in a dataindependent analysis mode. All analytical work was
performed within a climate-controlled clean room.
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Statistical Analysis
Aligned composite molecular profiles (separate
admission and discharge profiles per TBI subject) were
statistically tested using the MultiExperimentViewer (v.
4.8.1) informatics package for array data. Volcano plot
presentations were generated following a Welch’s t-test
methods with alpha adjusted to 0.01. The TBIresponsive “Urome” was evaluated across all 24
specimens using a non—parametric Kruskal-Wallis
method with alpha adjusted to 0.01, with results
presented in a heatmap format. Principle component
analysis was performed for data-reduction, with the first
two components plotted.
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Data Processing
Data were processed using PLGS software v.2.5.2
(Waters). Accurate mass and retention time (AMRT)
tables for triplicate specimens were merged to generate
a single composite molecular profile per subject that
accounted for intraday variance. All subject profiles were
aligned by AMRT values (±7 ppm mass accuracy; ± 0.5
min retention time) using Expressions software (v.2.5).
Non-reproducing AMRT measures (<3/group) were
removed. Values from a simulated Gaussian distribution
randomized about the limit of quantification were
imputed for left censored data denoting a non-random,
group-specific level below the detection limit. Intersubject normalization (median intensity, 1000 most
intense ions) and log(2) transformation procedures were
performed.

Conclusions

Results

1.

2.

The TBI urinary signature is distinct from matched controls. Further,
the TBI urinary signature evolves with time in recovery. Work is
ongoing to evaluate the clinical correlation of the temporally distinct
signatures and the precise nature of the underlying constituents. To
date we have determined that the TBI urinary signature includes a
compilation of peptides. These peptides are by-products from proteins
with an enriched relevance to neuroplasticity as illustrated in the table
below. Many peptides are derivatives from the terminal signaling motif
of the parent protein, denoting functional significance to their release
during a timeframe critical to rehabilitative intervention and rewiring of
circuits associated with lost function.

3.
Non-trauma
Controls

TBI-Rehab
Admission

p-value (-log10)

Regenerative Axis

TBI-Rehab
Discharge

Cutoff
p=0.01

Name

Class

ID

Qty

P-value

DLG4 (PSD95) binding/activity partners

Interactions

Int:DLG4

8

2.47e-3

Ncam signaling for neurite out-growth

Reactome

MSigDB:375165

7

5.65e-5

Involved in axon guidance

Reactome

MSigDB:422475

8

1.75e-3

Proteinaceous extracellular matrix

Cell Comp.

GO:0005578

18

5.86e-9

Tissue development

Bio. Process

GO:0009888

24

1.18e-3

Cell projection morphogenesis

Bio. Process

GO:0048858

15

2.78e-2

Extracellular matrix structural constituents

Mol. Function

GO:0005201

10

1.63e-8

Growth factor binding

Mol. Function

GO:0019838

6

3.87e-2

Regenerative Plasticity
Brain Injury Axis

Fold (Log2) Change from Control

Volcano plot resolving molecular factors that differentiate
the discharge urinary signature (‘urome”) from the
admission urinary signature of eight TBI patients. Paired ttest, p<0.01. There 11,763 biomolecules that were identified
and 2,139 (18%) met significance criteria differentiating TBI
admission from TBI discharge.
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Principle component analysis presents a multivariate reduction of TBI
“urome” signatures for admission (red) separated from discharge
(orange) as well as matched non-traumatized controls (green). The xaxis depicts the distinction of TBI subjects regardless of the collection time
post-TBI. The y-axis is discriminating based on time after injury
suggesting separate factors may be by-products of regenerative
neuropathobiology evolving during the post acute period.
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Environmental
Cues

Heatmap of differential molecular factors within the TBI urinary signature (“urome”).
Top: heatmap comprised of molecular factors selectively present during admission
to brain injury rehabilitation. Bottom: heatmap comprised of molecular factors
selectively present during discharge from brain injury rehabilitation. These results
underlie the “regeneration axis” in Figure 2, classifying specimens based on time
post-TBI / within rehabilitation. Red = increased, green = decreased, relative to
non-traumatized control subjects. Kruskal-Wallis, p<0.01.
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Dendritic
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NMDA / GABA
receptor shifts

Axonal
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Pruning /
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